Marianne de Backer, President and CEO at Vir Biotechnology, Inc. (VIR), sold 72,559 shares at $9.16 ($664K) on 2026-04-06, disclosed to the SEC on 2026-04-07.
Scheduled sale ($664k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VIR | SELL | 2025-04-04 | $949K | — | Filing → |
| VIR | SELL | 2025-02-25 | $305K | — | Filing → |
| VIR | SELL | 2024-04-04 | $1.4M | — | Filing → |